Quality of life, fatigue and depression in Italian long-term breast cancer survivors

2012 ◽  
Vol 20 (11) ◽  
pp. 2941-2948 ◽  
Author(s):  
Francesca Romito ◽  
Claudia Cormio ◽  
Francesco Giotta ◽  
Giuseppe Colucci ◽  
Vittorio Mattioli
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Cancer Survivors ◽  
Breast Cancer Survivors

Impact of age-related socio-economic and clinical determinants of quality of life among long-term breast cancer survivors

Maturitas ◽  
2015 ◽  
Vol 81 (3) ◽  
pp. 362-370 ◽  
Author(s):  
Pegdwende Olivia Dialla ◽  
Wai-On Chu ◽  
Patrick Roignot ◽  
Marie-Christine Bone-Lepinoy ◽  
Marie-Laure Poillot ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Cancer Survivors ◽  
Breast Cancer Survivors ◽  
Age Related

Abstract 1829: Predictors of quality of life among Hispanic and non-Hispanic White women: A 15 year follow-up study of long-term breast cancer survivors

2011 ◽  
Author(s):  
Stephanie R. Denkhoff ◽  
Dongyan Yang ◽  
Christina M. Pinkston ◽  
Richard N. Baumgartner ◽  
Kathy B. Baumgartner
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Cancer Survivors ◽  
Breast Cancer Survivors ◽  
White Women ◽  
Follow Up Study ◽  
Hispanic White

Long-term quality of life after breast cancer: comparison of 8-year survivors with population controls.

1998 ◽  
Vol 16 (2) ◽  
pp. 487-494 ◽  
Author(s):  
M Dorval ◽  
E Maunsell ◽  
L Deschênes ◽  
J Brisson ◽  
B Mâsse
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Cancer Survivors ◽  
Social Functioning ◽  
Breast Cancer Survivors ◽  
Consecutive Series ◽  
Improve Quality

PURPOSE Quality of life of breast cancer survivors 8 years after diagnosis was compared with that among similarly aged women who had never confronted cancer (controls). METHODS Survivors of a consecutive series of 227 breast cancer patients first treated in 1984 were approached for this study. Random-digit dialing was used to identify controls with the same age and residential distribution as the survivors. Quality of life was assessed in terms of physical health, functional status, psychologic distress, and social functioning. RESULTS Participation was obtained from 96% (n = 124) of 129 eligible survivors and 61% (n = 262) of 427 potentially eligible controls. Consistently smaller proportions of survivors reported positive quality-of-life outcomes compared with controls, but these differences were generally small and nonsignificant statistically. When limited to women who remained free of disease over the entire follow-up period (n = 98), survivors' quality of life was similar to that among controls, with the exception of arm problems and sexual satisfaction for those women who lived with a partner. In contrast, survivors who developed recurrence or new primary breast cancer (n = 26) experienced a worse quality of life in all domains except social functioning. CONCLUSION In most domains and for women without further disease events after diagnosis, quality of life does not seem to be permanently and globally impaired by breast cancer. Consequently, breast cancer survivors who remain free of disease probably do not need organized late psychosocial follow-up to improve quality of life. However, arm problems and sexuality are two areas in which additional effort may be still needed to improve quality of life of long-term survivors.

Determinants of quality of life among long-term breast cancer survivors

2016 ◽  
Vol 25 (8) ◽  
pp. 1981-1990 ◽  
Author(s):  
Wai-on Chu ◽  
Pegdwende Olivia Dialla ◽  
Patrick Roignot ◽  
Marie-Christine Bone-Lepinoy ◽  
Marie-Laure Poillot ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Cancer Survivors ◽  
Breast Cancer Survivors

The Quality of Life in Long-Term Breast Cancer Survivors with Breast Cancer Related Lymphedema

2014 ◽  
Vol 114 (4) ◽  
pp. 239-244 ◽  
Author(s):  
T. R. Lopez Penha ◽  
J. van Bodegraven ◽  
B. Winkens ◽  
E. M. Heuts ◽  
A. C. Voogdi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Cancer Survivors ◽  
Breast Cancer Survivors ◽  
Breast Cancer Related Lymphedema

scholarly journals Health-Related Quality of Life in a Cohort of Breast Cancer Survivors over More Than 10 Years Post-Diagnosis and in Comparison to a Control Cohort

Cancers ◽  
2021 ◽  
Vol 13 (8) ◽  
pp. 1854
Author(s):  
Tabea Maurer ◽  
Kathrin Thöne ◽  
Nadia Obi ◽  
Audrey Y. Jung ◽  
Sabine Behrens ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Cancer Survivors ◽  
Breast Cancer Survivors ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related ◽  
Over Time

Background: Breast cancer (BC) survivors often suffer from late and long-term residual symptoms of the disease and its treatment. To date, long-term health-related quality of life (HRQoL) in breast cancer survivors has been seldom investigated and rarely compared to unaffected women (controls). Aim: This study aimed to investigate HRQoL over time using patient-reported status before diagnosis, during treatment, 1 year post-surgery, approx. 5 years and ≥10 years post-diagnosis. We also compared survivors’ HRQoL with controls’ still alive 10 years after recruitment. Methods: Data from the German population-based Mamma Carcinoma Risk Factor Investigation (MARIE) cohort of 1123 BC patients aged 50–74 years at diagnosis (2002–2005) and of 3453 matched controls were used for analysis. HRQoL was assessed with the European Organization for Research and Treatment of Cancer (EORTC QLQ-C30) questionnaire. All analyses were conducted for all ages as well as stratified according to three age groups (≤58 years, 59–64 years, ≥64 years). Differences in survivors’ general HRQoL before, during, and after therapy were investigated using a t-test/Wilcoxon signed-rank test. Changes in the HRQoL of survivors stratified by age from FU1 to FU2 were assessed via repeated analysis of variance. The HRQoL of survivors compared to the controls at FU2 was analyzed using an analysis of variance. Results: Over all ages, the general HRQoL in patients improved in the first 5 years post-diagnosis. In the subsequent years, HRQoL slightly deteriorated but was comparable to that of the controls. Younger survivors mostly improved their HRQoL from the 5 to 10-year follow-up but remained negatively affected for most functioning and symptom scales compared to controls. In older survivors, HRQoL hardly changed over time and detriments were less pronounced compared to controls, except for insomnia. Conclusions: Restrictions of HRQoL persist for more than 10 years and are most prominent among younger survivors. Researchers and clinicians should be aware of such potential deteriorations and age-dependent differences in order to optimize/adapt long-term cancer survivor care.

Sign in / Sign up

Export Citation Format

Share Document